Literature DB >> 11181071

Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate.

C M Rodrigues1, S Solá, M A Brito, C D Brondino, D Brites, J J Moura.   

Abstract

Mitochondria have been implicated in the cytotoxicity of amyloid beta-peptide (A beta), which accumulates as senile plaques in the brain of Alzheimer's disease patients. Tauroursodeoxycholate (TUDC) modulates cell death, in part, by preventing mitochondrial membrane perturbation. Using electron paramagnetic resonance spectroscopy analysis of isolated mitochondria, we tested the hypothesis that A beta acts locally in mitochondrial membranes to induce oxidative injury, leading to increased membrane permeability and subsequent release of caspase-activating factors. Further, we intended to determine the role of TUDC at preventing A beta-induced mitochondrial membrane dysfunction. The results demonstrate oxidative injury of mitochondrial membranes during exposure to A beta and reveal profound structural changes, including modified membrane lipid polarity and disrupted protein mobility. Cytochrome c is released from the intermembrane space of mitochondria as a consequence of increased membrane permeability. TUDC, but not cyclosporine A, almost completely abrogated A beta-induced perturbation of mitochondrial membrane structure. We conclude that A beta directly induces cytochrome c release from mitochondria through a mechanism that is accompanied by profound effects on mitochondrial membrane redox status, lipid polarity, and protein order. TUDC can directly suppress A beta-induced disruption of the mitochondrial membrane structure, suggesting a neuroprotective role for this bile salt. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181071     DOI: 10.1006/bbrc.2001.4370

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis.

Authors:  Tao Zhang; Wolfgang Baehr; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

2.  Alzheimer's disease protein Abeta1-42 does not disrupt isolated synaptic vesicles.

Authors:  Peter B Allen; Daniel T Chiu
Journal:  Biochim Biophys Acta       Date:  2008-02-20

Review 3.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 4.  Emerging Advances in the Management of Cardiac Amyloidosis.

Authors:  Michael N Vranian; Brett W Sperry; Jason Valent; Mazen Hanna
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

5.  Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.

Authors:  Pravat K Mandal; Jay W Pettegrew
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

6.  Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice.

Authors:  Jae-Seong Yang; Jin Taek Kim; Jouhyun Jeon; Ho Sun Park; Gyeong Hoon Kang; Kyong Soo Park; Hong Kyu Lee; Sanguk Kim; Young Min Cho
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

7.  Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.

Authors:  C Dirk Keene; Cecilia M P Rodrigues; Tacjana Eich; Manik S Chhabra; Clifford J Steer; Walter C Low
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats.

Authors:  Cecilia M P Rodrigues; Susana Sola; Zhenhong Nan; Rui E Castro; Paulo S Ribeiro; Walter C Low; Clifford J Steer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

9.  Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway.

Authors:  Susana Solá; Rui E Castro; Pedro A Laires; Clifford J Steer; Cecília M P Rodrigues
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

10.  Bile acids in treatment of ocular disease.

Authors:  Jeffrey H Boatright; John M Nickerson; Anisha G Moring; Machelle T Pardue
Journal:  J Ocul Biol Dis Infor       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.